Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diseases of the Skin and Subcutaneous Tissue”

361 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 361 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07000292
What this trial is testing

MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

Who this might be right for
Lupus Nephritis (LN)ANCA-Associated Glomerulonephritis
Shanghai Changzheng Hospital 12
Post-approval studies (Phase 4)Study completedNCT03055494
What this trial is testing

Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 102
Testing effectiveness (Phase 2)Active Not RecruitingNCT05139602
What this trial is testing

Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Who this might be right for
Hidradenitis Suppurativa
AbbVie 210
Early research (Phase 1)Active Not RecruitingNCT07078695
What this trial is testing

A Trial of SHR-1139 in Healthy Volunteers

Who this might be right for
Psoriasis
Atridia Pty Ltd. 24
Not applicableStudy completedNCT04781439
What this trial is testing

The Effect of Early Switching From Intravenous to Oral Antibiotics Therapy

Who this might be right for
Skin and Subcutaneous Tissue Infection
Gia Dinh People Hospital 210
Large-scale testing (Phase 3)Study completedNCT01605136
What this trial is testing

Phase III Confirmatory Study in Erythropoietic Protoporphyria

Who this might be right for
Erythropoietic Protoporphyria
Clinuvel Pharmaceuticals Limited 93
Testing effectiveness (Phase 2)Active Not RecruitingNCT06565273
What this trial is testing

Study to Investigate the Efficacy, Safety, and Tolerability of FBL-MTX in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
SOLFARCOS - Pharmaceutical and Cosmetic Solutions Ltd 40
Testing effectiveness (Phase 2)Study completedNCT01987609
What this trial is testing

Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques

Who this might be right for
Psoriasis
Tissa Hata, MD 7
Large-scale testing (Phase 3)Study completedNCT01365455
What this trial is testing

Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 738
Large-scale testing (Phase 3)Enrolling By InvitationNCT07223138
What this trial is testing

Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
MoonLake Immunotherapeutics AG 1,560
Testing effectiveness (Phase 2)Study completedNCT01382589
What this trial is testing

Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Light in the Treatment of Nonsegmental Vitiligo

Who this might be right for
Vitiligo
Clinuvel Pharmaceuticals Limited 15
Not applicableNot Yet RecruitingNCT07395674
What this trial is testing

Subcutaneous Dexpanthenol Administration and Wound Epithelialization

Who this might be right for
Chronic WoundsDiabetic Foot UlcerVenous Leg Ulcers+1 more
Dilara CANBAY OZDEMIR 40
Large-scale testing (Phase 3)Active Not RecruitingNCT06641076
What this trial is testing

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug

Who this might be right for
Arthritis, Psoriatic
MoonLake Immunotherapeutics AG 960
Large-scale testing (Phase 3)Looking for participantsNCT07430306
What this trial is testing

Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 245
Testing effectiveness (Phase 2)Study completedNCT02962960
What this trial is testing

Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 36
Early research (Phase 1)Study completedNCT04885829
What this trial is testing

Comparative Study of 3 Tocilizumab Products in Normal Healthy Volunteeers

Who this might be right for
Rheumatoid ArthritisGiant Cell Arteritis
Syneos Health 300
Post-approval studies (Phase 4)Ended earlyNCT02659150
What this trial is testing

Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Massachusetts General Hospital 16
Not applicableUnknownNCT03880188
What this trial is testing

Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds

Who this might be right for
Wounds and InjuriesWound InfectionFacial Bones Fracture+16 more
Dufresne, Craig, MD, PC 20
Large-scale testing (Phase 3)WithdrawnNCT02074020
What this trial is testing

CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Anthera Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT01756157
What this trial is testing

Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema Attacks

Who this might be right for
Hereditary Angioedema (HAE)
Shire 47
Next Page